Proposal to fund medicines for people with high blood pressure and bacterial infections
The Pharmaceutical Management Agency proposes funding ceftolozane with tazobactam and widening access to bedaquiline, linezolid and captopril liquid for specified infections and high blood pressure.
- Closing date
- 29 September 2026
- Added to Civics
- 17 September 2026
- Source category
- Other public body
- Source body
- Pharmaceutical Management Agency
- Last checked
- 23 September 2026
Closes in 6 days
Plain-English summary
The Pharmaceutical Management Agency proposes funding ceftolozane with tazobactam and widening access to bedaquiline, linezolid and captopril liquid for specified infections and high blood pressure.
Read the official consultation material for the detailed proposal, supporting documents and submission method.
Why it matters
The changes would fund these medicines for the specified indications if approved.
Who may care
- Family/whānau of someone who uses medicines
- Friend of someone who uses medicines
- Other health care professionals
How to make a submission
- Read the official consultation material.
- Submit feedback through the official consultation page before the closing date.
Disclaimer
Civics.nz is an independent plain-English guide and is not an official government website. Always check the official source before making a submission.